Wilmington Savings Fund Society FSB Lowers Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Wilmington Savings Fund Society FSB cut its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 36.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,528 shares of the pharmacy operator’s stock after selling 3,717 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in Walgreens Boots Alliance were worth $61,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. Charles Schwab Investment Management Inc. raised its stake in Walgreens Boots Alliance by 43.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after purchasing an additional 3,329,857 shares during the period. Altrius Capital Management Inc raised its position in shares of Walgreens Boots Alliance by 76.6% during the third quarter. Altrius Capital Management Inc now owns 440,483 shares of the pharmacy operator’s stock valued at $3,947,000 after buying an additional 190,996 shares during the last quarter. Swedbank AB lifted its holdings in shares of Walgreens Boots Alliance by 45.3% in the fourth quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator’s stock worth $5,559,000 after buying an additional 185,762 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in shares of Walgreens Boots Alliance by 23.4% during the third quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator’s stock worth $3,050,000 after acquiring an additional 64,586 shares during the last quarter. Finally, Sasco Capital Inc. CT grew its stake in Walgreens Boots Alliance by 13.6% during the third quarter. Sasco Capital Inc. CT now owns 1,041,440 shares of the pharmacy operator’s stock valued at $9,331,000 after acquiring an additional 124,950 shares in the last quarter. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Price Performance

WBA stock opened at $9.75 on Friday. The stock has a market cap of $8.43 billion, a PE ratio of -0.95, a P/E/G ratio of 1.26 and a beta of 0.65. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.47. The company has a 50-day moving average price of $10.26 and a 200 day moving average price of $9.77. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same quarter in the previous year, the business earned $0.66 earnings per share. The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analysts Set New Price Targets

WBA has been the subject of several research reports. Bank of America increased their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Royal Bank of Canada increased their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Evercore ISI lifted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Truist Financial lowered their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Finally, UBS Group raised their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $13.19.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.